Internal Medicine
M-A | Antibiotics for preventing recurrent urinary tract infection.
4 Jul, 2022 | 12:17h | UTCBrief Review | Ventilator-associated pneumonia.
4 Jul, 2022 | 12:15h | UTCVentilator-associated pneumonia – Intensive Care Medicine (if the link is paywalled, try this one in PMC)
Commentary on Twitter
VAP, main challenges & lessons learned
➡️ epidemiology: surveillance & data from LMICs
➡️ pathophysiology
➡️ prevention bundle
➡️ gold standard for diagnosis & microbiology
➡️ treatment: appropriate/timely ABTs
➡️ MDR pathogens
➡️ #COVID19: VAP's back
📎 https://t.co/oYblI6OGLK pic.twitter.com/qXWcABsU0H— Intensive Care Medicine (@yourICM) July 1, 2022
Review | Lowering and raising serum urate levels: off-label effects of commonly used medications.
4 Jul, 2022 | 12:10h | UTCHow doctors manage conflicts with families of critically ill patients during conversations about end-of-life decisions in neonatal, pediatric, and adult intensive care.
4 Jul, 2022 | 12:13h | UTC2022 Guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
1 Jul, 2022 | 11:50h | UTCRelated:
Two new studies show no benefit of Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19.
1 Jul, 2022 | 11:49h | UTCCommentaries:
Antithrombotic Prophylaxis No Help in Outpatients With COVID — Two trials show no differences between patients who received enoxaparin vs standard of care – MedPage Today (free registration required)
Commentary on Twitter (thread – click for more)
Early in the pandemic we wondered whether antithrombotic therapy in outpatients with #COVID19 would prevent #thrombosis ❓
Several trials were started globally and the ACTIV-4B trial was previously reported⬇️ https://t.co/Q15WcZwDIA
Now, we publish the OVID and ETHIC trials🧵
— The Lancet Haematology (@TheLancetHaem) June 30, 2022
Accuracy of rapid antigen vs. RT-PCR testing for SARS-CoV-2 infection in college athletes during prevalence of the Omicron variant.
1 Jul, 2022 | 11:39h | UTC
Commentary on Twitter
In this case series of college athletes returning to campus during Omicron, rapid antigen tests were 63% sensitive, >99% specific for #COVID19, similar to previous strains and less well in detecting asymptomatic #SARSCoV2. @helixcardinal @stanford_ortho https://t.co/SBPr6NQ9Na
— JAMA Network Open (@JAMANetworkOpen) June 15, 2022
Consensus for the definition, classification, diagnosis, and management of urticaria.
1 Jul, 2022 | 11:32h | UTC
Safety of empagliflozin in patients with Type 2 Diabetes and chronic kidney disease: pooled analysis of placebo-controlled clinical trials.
1 Jul, 2022 | 10:44h | UTC
Life’s Essential 8: Updating and enhancing the AHA construct of cardiovascular health.
30 Jun, 2022 | 11:31h | UTCNews Release: American Heart Association adds sleep to cardiovascular health checklist
Commentary: Sleep duration matters for heart health, according to new recommendations – CNN
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.
30 Jun, 2022 | 11:26h | UTC
RCT: Effects of early Empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure.
30 Jun, 2022 | 11:24h | UTC
Cohort Study: Association of time elapsed since ischemic stroke with risk of recurrent stroke in older patients undergoing elective nonneurologic, noncardiac surgery.
30 Jun, 2022 | 11:16h | UTCAssociation of Time Elapsed Since Ischemic Stroke With Risk of Recurrent Stroke in Older Patients Undergoing Elective Nonneurologic, Noncardiac Surgery – JAMA Surgery (free for a limited period)
Invited Commentary: Perioperative Stroke Risk Model—One Size Fits All? – JAMA Surgery
Secondary analysis of a RCT: Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes.
30 Jun, 2022 | 10:58h | UTCOriginal Study: Empagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine
Brief Review: Update on prevention of intra-vascular accesses complications.
30 Jun, 2022 | 10:38h | UTCUpdate on prevention of intra-vascular accesses complications – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Update on intra-vascular accesses complications
🎯 choice
🗝 key measures to prevent CRBSI
Most of times CVL essential in #ICU but deescalation to PVL to be promoted. ⬆️ occlusions/thrombosis w midline/PICCS, CRBSI similar to CVL; interesting out ICU.
🖇 https://t.co/XVxJDkOL4i pic.twitter.com/iIQNEXctoe— Intensive Care Medicine (@yourICM) June 30, 2022
Case-Control Study: Outcomes and risk factors for delayed-onset postoperative respiratory failure.
30 Jun, 2022 | 10:34h | UTC
RCT: A 2-week interruption in methotrexate treatment doubles the antibody response to a COVID-19 booster vaccine.
29 Jun, 2022 | 12:10h | UTCNews Releases:
Interrupting immune-suppressing treatment can boost COVID vaccine response – Imperial College London
Commentaries:
Commentary on Twitter
NEW Research—2-week interruption of methotrexate treatment for people w/ immune-mediated inflammatory diseases = enhanced boosting of antibody responses after #COVID19 vaccination
From Prof Abhishek Abhishek & colleagues https://t.co/y14pUEaB5X pic.twitter.com/pLvaXjJzoz
— The Lancet Respiratory Medicine (@LancetRespirMed) June 28, 2022
M-A: Comparison of mortality and hospital readmissions among patients receiving virtual ward transitional care vs. usual postdischarge care.
29 Jun, 2022 | 12:06h | UTC
Commentary on Twitter
In this systematic review and meta-analysis of 24 RCTs, post-discharge virtual ward care was associated with reduced all-cause mortality, hospital readmission, and healthcare costs in patients with heart failure. https://t.co/yMx7F52L5S
— JAMA Network Open (@JAMANetworkOpen) June 28, 2022
Review: Common hand conditions.
29 Jun, 2022 | 11:57h | UTCCommon Hand Conditions: A Review – JAMA (free for a limited period)
Audio Clinical Review: Diagnosis and Treatment of Common Hand Conditions
An analysis of SARS-CoV-2 vaccine reactogenicity: variation by type, dose, and history, severity, and recency of prior SARS-CoV-2 infection.
29 Jun, 2022 | 11:52h | UTC
Guideline: Differential diagnosis of acute and chronic redness of the lower legs.
29 Jun, 2022 | 11:42h | UTC
Lipid guidelines for primary prevention.
29 Jun, 2022 | 11:31h | UTC2022 Taiwan lipid guidelines for primary prevention – Journal of the Formosan Medical Association
Network meta-analysis: Dipeptidyl peptidase-4 inhibitors increase the risk of cholecystitis in patients with type 2 diabetes.
29 Jun, 2022 | 11:24h | UTC
Pharmacological management of hypertrophic cardiomyopathy: from bench to bedside.
29 Jun, 2022 | 11:01h | UTCPharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside – Drugs
Retrospective Cohort Study: Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure.
29 Jun, 2022 | 10:52h | UTCOriginal Study: Post-operative atrial fibrillation and risk of heart failure hospitalization – European Heart Journal
Commentary on Twitter
Excited to have been part of this study with @ParagGoyalMD and our @WeillCornell colleagues
We found post-operative AF is associated with a higher long-term risk of HF hospitalization 👇https://t.co/X9eh2D9V71 @ESC_Journals @WCMCNeurology pic.twitter.com/5HlsGfOq1j
— Hooman Kamel (@hoomankamel) June 29, 2022